OOIR: Observatory of International Research

Papers

(The H4-Index of Ophthalmology is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045	911
International Classification of Retinopathy of Prematurity, Third Edition	348
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration	268
HAWK and HARRIER	236
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab	215
Primary Open-Angle Glaucoma Preferred Practice Pattern®	183
Multifocal and Extended Depth-of-Focus Intraocular Lenses in 2020	140
The Risks and Benefits of Myopia Control	129
Update on Intraocular Lens Power Calculation Study Protocols	125
Polypoidal Choroidal Vasculopathy	120
Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children	120
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration	117
Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma	108
Nonadherence or Nonpersistence to Intravitreal Injection Therapy for Neovascular Age-Related Macular Degeneration	108
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease	107
Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout	95
Five-Year Follow-up of First 11 Patients Undergoing Injection of Cultured Corneal Endothelial Cells for Corneal Endothelial Failure	92
Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset	91
Intraocular Lens Power Formulas, Biometry, and Intraoperative Aberrometry	86
COVID-19 Quarantine Reveals That Behavioral Changes Have an Effect on Myopia Progression	86
Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2	85
Evaluation of SARS-CoV-2 in Tears of Patients with Moderate to Severe COVID-19	83
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment	81
The Association between Vision Impairment and Incidence of Dementia and Cognitive Impairment	80
Prevalence of Keratoconus Based on Scheimpflug Imaging	80

Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning	79
Time Outdoors in Reducing Myopia	74
Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children	72
Phase 3, Randomized, 20-Month Study of Bimatoprost Implant in Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 1)	70
Evolution of the Prevalence of Myopia among Taiwanese Schoolchildren	70
Trends in Glaucoma Surgeries Performed by Glaucoma Subspecialists versus Nonsubspecialists on Medicare Beneficiaries from 2008 through 2016	68
Comparison of Myopic Progression before, during, and after COVID-19 Lockdown	66
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy	65
Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children	63
Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial	63
Increased Time Outdoors Is Followed by Reversal of the Long-Term Trend to Reduced Visual Acuity in Taiwan Primary School Students	62
Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe	62
Disparities in Vision Health and Eye Care	62
Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia	61
Socioeconomic and Demographic Disparities in the Use of Telemedicine for Ophthalmic Care during the COVID-19 Pandemic	61
Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery	60
Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT	60
Cataract in the Adult Eye Preferred Practice Pattern®	59
Detection of Progressive Glaucomatous Optic Nerve Damage on Fundus Photographs with Deep Learning	56
Primary Angle-Closure Disease Preferred Practice Pattern®	56
The Economic Burden of Vision Loss and Blindness in the United States	56
Autologous Retinal Transplantation for Primary and Refractory Macular Holes and Macular Hole Retinal Detachments	55
Atropine for the Treatment of Childhood Myopia in India: Multicentric Randomized Trial	55
Assessing Glaucoma Progression Using Machine Learning Trained on Longitudinal Visual Field and Clinical Data	55
Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease	54
OCT Angiography for the Diagnosis of Glaucoma	53
Racial and Socioeconomic Differences in Eye Care Utilization among Medicare Beneficiaries with Glaucoma	52
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2	52
Intraocular Lens Power Calculations in Eyes with Previous Corneal Refractive Surgery	52
Myopia Control Effect of Repeated Low-Level Red-Light Therapy in Chinese Children	52